- Home
- ICCC vs LFWD Comparison
ICCC vs LFWD Comparison
Compare ICCC & LFWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- LFWD
- Stock Information
- Founded
- ICCC 1982
- LFWD 2001
- Country
- ICCC United States
- LFWD Israel
- Employees
- ICCC N/A
- LFWD N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- LFWD
- Sector
- ICCC Health Care
- LFWD
- Exchange
- ICCC Nasdaq
- LFWD NYSE
- Market Cap
- ICCC 28.7M
- LFWD 27.0M
- IPO Year
- ICCC 1987
- LFWD 2014
- Fundamental
- Price
- ICCC $3.55
- LFWD $2.50
- Analyst Decision
- ICCC
- LFWD Strong Buy
- Analyst Count
- ICCC 0
- LFWD 1
- Target Price
- ICCC N/A
- LFWD $13.00
- AVG Volume (30 Days)
- ICCC 20.8K
- LFWD 31.1K
- Earning Date
- ICCC 11-13-2024
- LFWD 11-28-2024
- Dividend Yield
- ICCC N/A
- LFWD N/A
- EPS Growth
- ICCC N/A
- LFWD N/A
- EPS
- ICCC N/A
- LFWD N/A
- Revenue
- ICCC $23,222,929.00
- LFWD $23,277,000.00
- Revenue This Year
- ICCC N/A
- LFWD $124.19
- Revenue Next Year
- ICCC N/A
- LFWD $44.50
- P/E Ratio
- ICCC N/A
- LFWD N/A
- Revenue Growth
- ICCC 48.05
- LFWD 313.30
- 52 Week Low
- ICCC $3.34
- LFWD $2.45
- 52 Week High
- ICCC $5.59
- LFWD $9.10
- Technical
- Relative Strength Index (RSI)
- ICCC 43.90
- LFWD 26.11
- Support Level
- ICCC $3.51
- LFWD $2.45
- Resistance Level
- ICCC $3.74
- LFWD $3.10
- Average True Range (ATR)
- ICCC 0.17
- LFWD 0.13
- MACD
- ICCC 0.00
- LFWD -0.03
- Stochastic Oscillator
- ICCC 18.60
- LFWD 6.92
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.